Peptide API Liraglutide/Liraglutide acetate CAS 204656-20-2
Min.Order / FOB Price:Get Latest Price
| 1 Gram |
Negotiable |
- Min.Order :1 Gram
- Purity: 98% Min
- Payment Terms : T/T,
Keywords
Liraglutide supplier, peptide hormone Liraglutide acetate Liraglutide manufacturer
Quick Details
- Appearance:White powder
- Application:pharmaceutical ingredients ,research chemicals
- PackAge:According client's requirements
- ProductionCapacity:200|Gram|Day
- Storage:keep sealed and keep from direct light
- Transportation:According client's requirements
Superiority:
Our Advantages:
1.Product Capacity: eptidego has produced thousands of peptides ranging in quantity from milligrams to multiple kilograms with purities up to 99.0%.
2. Samples free trial: our company welcome samples to test our quality then make regular orders.
3. Good Service: the company have 24 hours online service and feedback to our clients ontime
4. Quality guarantee: We have strict quality control system before our delivery and refunds or re-deliver if any quality problems.
5. Fast Delivery and safe shipping: The compnay process orders in time and have much experienced in internation shipping, always keep goods safe shipping and fast delivery.
Details:
About Liraglutide/Liraglutide acetate CAS 204656-20-2
| Name | Liraglutide/Liraglutide acetate |
| Synonyms | NN 2211; NNC 90-1170; Victoza |
| CAS NO. | 204656-20-2 |
|
Molecular Formula |
C172H265N43O51 |
| Molecular Weight | 3751.20 |
| Appearance | White Powder |
| Purity | 99% Min |
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment oftype 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. and E.U. under the brand name Saxenda as a treatment for adults, who are obese or overweight with at least one weight-relatedcomorbid condition.
Usage
Liraglutide is a once-daily injectable derivative of the human incretin (metabolic hormone) glucagon-like peptide-1 (GLP-1), for the treatment of type 2 diabetes or obesity.
|
Test |
Specification |
Result |
|---|---|---|
|
Appearance |
White powder |
conforms |
|
MS |
3751.3±1.0 |
conforms |
|
Related Substances （purity） |
Unspecified impurity for each impurity: NMT1.0%
Total impurity: NMT 2.0% |
0.29%(single largest impurity)
1.18% |
|
Acetic acid |
NMT 8.0% |
0.5% |
|
Water Content(Karl Fischer） |
NMT 7.0% |
4.8% |
|
Peptide Content(N%) |
NLT80% |
94.5% |
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View